Cell ReportsCancer BiologyPeer-reviewed journal article
MAPK14/p38α Shapes the Molecular Landscape of Endometrial Cancer and promotes Tumorigenic Characteristics
Sayali JosephiD, Xingyuan ZhangiD, Gaith N. DrobyiD, Di WuiD, Victoria Lin Bae-JumpiD, Scott Lyons, Angie L. MordantiD, Allie Mills, Laura E. HerringiD, Blake R. RushingiD, Jessica L. BowseriD, Cyrus VaziriiD
Abstract
The molecular underpinnings of High Grade Endometrial Carcinoma (HGEC) metastatic growth and survival are poorly understood. Here we show that ascites-derived and primary tumor HGEC cell lines in 3D spheroid culture faithfully recapitulate key features of malignant peritoneal effusion and exhibit fundamentally distinct transcriptomic, proteomic and metabolomic landscapes when compared with conventional 2D monolayers. Using genetic screening platform we identify MAPK14 (which encodes the protein kinase p38) as a specific requirement for HGEC in spheroid culture. MAPK14/p38 has broad roles in programing the phosphoproteome, transcriptome and metabolome of HGEC spheroids, yet has negligible impact on monolayer cultures. MAPK14 promotes tumorigenicity in vivo and is specifically required to sustain a sub-population of spheroid cells that is enriched in cancer stemness markers. Therefore, spheroid growth of HGEC activates unique biological programs, including p38 signaling, that cannot be captured using 2D culture models and are highly relevant to malignant disease pathology.
- organism: human
- assay: bulk RNA-seq
- assay: proteomics
- assay: metabolomics
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
- Citations
- 20
- FWCI
- 3.53
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeting IDH1 as a pro-senescent therapy in high-grade serous ovarian cancer
E. S. Dahl, R. Buj, … K. M. Aird·bioRxiv·Nov 17, 2018
- Both Fallopian Tube and Ovarian Surface Epithelium Can Act as Cell-of-Origin for High Grade Serous Ovarian Carcinoma
B. G. Neel, S. Zhang, … D. A. Levine·bioRxiv·Nov 29, 2018
- Preservation of stemness in high-grade serous ovarian cancer organoids requires low Wnt environment
K. Hoffmann, H. Berger, … M. Kessler·bioRxiv·Aug 21, 2019
- Keratin 5 marks cancer-propagating cells sustained by an osteopontin-producing niche in high-grade serous ovarian carcinoma
Mallikarjun Bidarimath, Coulter Q. Ralston, … Alexander Yu. Nikitin·Cancer Heterogeneity and PlasticityPeer-reviewed·Apr 25, 2026
- Multi-modal characterization of transcriptional programs that drive metastatic cascades to solid sites and ascites in ovarian cancer
Kaiyang Zhang, Essi Kahelin, … Sampsa Hautaniemi·bioRxiv·Aug 26, 2025
- Characterization of a novel estrogen- and progesterone-responsive endometrial cancer cell line: HCI-EC-23
C. M. Rush, Z. Blanchard, … J. Gertz·bioRxiv·Aug 25, 2022